These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 18164605)

  • 1. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic images of the disintegration process of tablets in the human stomach by ac biosusceptometry.
    Corá LA; Andreis U; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Phys Med Biol; 2005 Dec; 50(23):5523-34. PubMed ID: 16306649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
    Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
    Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrasion of tablets during scale-up: the influence of different crushing forces in laboratory and production perforated pan coaters.
    Mueller R; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):458-63. PubMed ID: 17475452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the disintegration of tablets in biorelevant media.
    Anwar S; Fell JT; Dickinson PA
    Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of die-wall instrumentation for research and development in tabletting.
    Doelker E; Massuelle D
    Eur J Pharm Biopharm; 2004 Sep; 58(2):427-44. PubMed ID: 15296965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.
    Massimo G; Santi P; Colombo G; Nicoli S; Zani F; Colombo P; Bettini R
    AAPS PharmSciTech; 2003; 4(2):E17. PubMed ID: 12916899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of oral disintegration time of fast disintegrating tablets using texture analyzer and computational optimization.
    Szakonyi G; Zelkó R
    Int J Pharm; 2013 May; 448(2):346-53. PubMed ID: 23558313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical applications of AC biosusceptometry.
    Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
    Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imaging.
    Roggo Y; Jent N; Edmond A; Chalus P; Ulmschneider M
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):100-10. PubMed ID: 16005618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonic determination of Young's moduli of the coat and core materials of a drug tablet.
    Akseli I; Becker DC; Cetinkaya C
    Int J Pharm; 2009 Mar; 370(1-2):17-25. PubMed ID: 19059326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics.
    Goel H; Arora A; Tiwary AK; Rana V
    Pharm Dev Technol; 2011 Feb; 16(1):57-64. PubMed ID: 20028210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression - a proof-of-concept study.
    Orubu SE; Hobson NJ; Basit AW; Tuleu C
    J Pharm Pharmacol; 2017 Apr; 69(4):417-431. PubMed ID: 27349946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole.
    Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.